Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101

Clinical trial NCT03644459 · WITHDRAWN

Trial details

NCT number: NCT03644459
Sponsor: Lynkcell Inc.
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Cancer Cervical Cancer Colorectal Cancer Stomach Cancer

Start date: 2019-04-03
Primary completion: 2020-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.